# Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study

> **NCT06588257** · PHASE4 · COMPLETED · sponsor: **Fundación Huésped** · enrollment: 101 (actual)

## Conditions studied

- HPV

## Interventions

- **BIOLOGICAL:** Non-infectious adjuvanted recombinant nonavalent HPV vaccine

## Key facts

- **NCT ID:** NCT06588257
- **Lead sponsor:** Fundación Huésped
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-09
- **Primary completion:** 2026-05-04
- **Final completion:** 2026-05-04
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06588257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06588257, "Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT06588257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*